[1] ZENG Z C, SEONG J, YOON S M, et al.Consensus on Stereotactic Body Radiation Therapy for Small-Sized Hepatocellular Carcinoma at the 7th Asia-Pacific Primary Liver Cancer Expert Meeting[J]. Liver Cancer, 2017, 6(4): 264-274.
[2] KIM N, CHENG J, JUNG I, et al.Stereotactic Body Radiation Therapy vs. Radiofrequency Ablation in Asian Patients With Hepatocellular Carcinoma[J]. J Hepatol, 2020, 73(1): 121-129.
[3] CHEN Y X, ZHUANG Y, YANG P, et al.Helical IMRT-Based Stereotactic Body Radiation Therapy Using an Abdominal Compression Technique and Modified Fractionation Regimen for Small Hepatocellular Carcinoma[J]. Technol Cancer Res Treat, 2020, 19: 1533033820937002.
[4] SU T S, LIANG P, LIANG J, et al.Long-Term Survival Analysis of Stereotactic Ablative Radiotherapy Versus Liver Resection for Small Hepatocellular Carcinoma[J]. Int J Radiat Oncol Biol Phys, 2017, 98(3): 639-646.
[5] HARA K, TAKEDA A, TSURUGAI Y, et al.Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: A Propensity Score Analysis[J]. Hepatology, 2019, 69(6): 2533-2545.
[6] HUO Y R, ESLICK G D.Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis[J]. JAMA Oncol, 2015, 1(6): 756-765.
[7] WEI X, JIANG Y, ZHANG X, et al.Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study[J]. J Clin Oncol, 2019, 37(24): 2141-2151.
[8] SUN J X, YANG L, SHI J, et al.Postoperative adjuvant IMRT for patients with HCC and portal vein tumor thrombus: An open-label randomized controlled trial[J]. Radiother Oncol, 2019, 140: 20-25.
[9] YOON S M, RYOO B Y, LEE S J, et al.Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Randomized Clinical Trial[J]. JAMA Oncol, 2018, 4(5): 661-669.
[10] CHONG J U, CHOI G H, HAN D H, et al.Downstaging with Localized Concurrent Chemoradiotherapy Can Identify Optimal Surgical Candidates in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus[J]. Ann Surg Oncol, 2018, 25(11): 3308-3315.
[11] ZHANG H G, SUN J, CHEN Y X, et al.Image-guided IMRT improves short-term survival for abdominal lymph node metastases from hepatocellular carcinoma[J]. Ann Palliat Med, 2019, 8(5): 717-727.
[12] SUN T W, HE J, ZHANG S M, et al.Simultaneous multitarget radiotherapy using helical tomotherapy and its combination with sorafenib for pulmonary metastases from hepatocellular carcinoma[J]. Oncotarget, 2016, 7(30): 48586-48599.
[13] HE J, SHI S, YE L, et al.A randomized trial of conventional fraction versus hypofraction radiotherapy for bone metastases from hepatocellular carcinoma[J]. J Cancer, 2019, 10(17): 4031-4037.
[14] YUAN B Y, HU Y, ZHANG L, et al.Radiotherapy for adrenal gland metastases from hepatocellular carcinoma[J]. Clin Transl Oncol, 2017, 19(9): 1154-1160. |
